This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Naurex grosses $38mm in Series B round led by Baxter Ventures; adds $25mm
28 Jul 2015
First-time investor Baxter Ventures has led a $38mm Series B financing for Naurex Inc. (developing CNS compounds that safely modulate the NMDA receptor). Another new backer Savitr Capital participated along with returning shareholders Adams Street Partners, Latterell Venture Partners, Genesys Capital, PathoCapital, Druid BioVentures, Northwestern University, H. Lundbeck AS, Takeda Ventures, Shire PLC, and private investors.
Drug Discovery Tools
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?